Stem cell transplantation.
AUTOR(ES)
Hajdu, K
RESUMO
Modern physicians desire not only to treat but to cure congenital diseases. In a wide variety of diseases, bone marrow transplantation can be the tool of final cure. The limitations and risks of this procedure have motivated researchers to search for an earlier and safer method of treatment. Special features of fetal immune systems make it possible to perform the transplantation during fetal life using fetal hematopoietic stem cells, thus avoiding many of the side effects of bone marrow transplantation in neonatal life. We review the experimental work done with animal models in this field and the human trials that have been published recently.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1011350Documentos Relacionados
- Polymicrobial infection of the oral mucosa after hematopoietic stem cell transplantation. Case report
- Spermatogenesis following male germ-cell transplantation.
- Peripheral blood stem cells used to augment autologous bone marrow transplantation.
- Persistence of hepatic hepatitis B virus after serological clearance of HBsAg with autologous peripheral stem cell transplantation.
- Pulmonary transplantation.
